Abstract
Current experience in intraocular fine needle aspiration biopsy in Mexican-Mestizo population
Highlights
Hisrchberg performed the first intraocular biopsy in 1868 [1] Jackobiec published his experience in 1979
In order to minimize serious potential eye complications we strongly advice intraocular fine-needle aspiration biopsy (FNAB) to be performed by trained subspecialists and the microscopic evaluation should be interpreted by an expert ophthalmic pathologist
The accepted indications for intraocular FNAB are 1) Major diagnostic uncertainty, 2) Amelanotic mass in a patient with history of previous non ocular malignancy, 3) Patient refuses treatment until malignancy is confirmed, 4) Suspected re-growth following an intraocular mass, 5) Prognostication is requiered, 6) Patient agree to be included in a scientific study [4], 7) Amelanotic mass in a patient without history of systemic malignancy
Summary
Hisrchberg performed the first intraocular biopsy in 1868 [1] Jackobiec published his experience in 1979. Since fineneedle aspiration (FNAB) biopsy in the eye, has been used for several intraocular tumors [2]. In underdeveloped countries this diagnostic tool has been left aside, because the fear of tumoral seeding in to the needle tract [3], the lack of technology for adequate specimen processing and accurate interpretation. Since the first intraocular biopsy performed in 1868 [1] by Hirshberg and experience published by Jackobiec in 1979, fine-needle aspiration biopsy (FNAB) in the eye has been used for several intraocular tumors [2].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
